E.AntunesT
Rybelsus (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU
Frequently Asked Questions About GLP-1 Weight Loss and Skin Laxity GLP-1 medications do not directly cause loose skin, but the weight loss that occurs while using them can make skin laxity more noticeable
Furthermore, H&E staining showed that compared to the aorta of normal aging mice, the aorta of mice treated with FOXO4-DRI was thinner, and the PWV value was lower in the ultrasound detection results, which means that the mice treated with FOXO4-DRI had better vascular elasticity and better vascular function than normal aging mice (Figures 1D,E)
However, in unvaccinated patients, GLP-1RA use was associated with a higher risk of composite outcomes (HR: 1.227, 95% CI: 1.1451.315) and herpes simplex (HR:1.347, 95% CI: 1.2021.509) and herpes zoster (HR:1.165, 95% CI: 1.0681.269) infections compared with DPP-4i